Synthesis of N-succinimidyl 4-[18F] fluorobenzoate, an agent for labeling proteins and peptides with 18F

被引:118
作者
Vaidyanathan, Ganesan [1 ]
Zalutsky, Michael R. [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/nprot.2006.264
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
This protocol describes the step-by-step procedure for the synthesis of N-succinimidyl 4-[F-18] fluorobenzoate ([F-18]SFB), an agent widely used for labeling proteins and peptides with the positron-emitting radionuclide F-18. The protocols for the synthesis of unlabeled SFB and the quaternary salt precursor 4- formyl-N, N, N-trimethyl benzenaminium trifluoromethane sulfonate also are described. For the [F-18] SFB synthesis, the quaternary salt is first converted to 4-[F-18]fluorobenzaldehyde. Oxidation of the latter provides 4-[F-18] fluorobenzoic acid, which is converted to [F-18] SFB by treatment with N,N-disuccinimidyl carbonate. Using this method, [F-18] SFB can be synthesized in decay-corrected radiochemical yields of 30%-35% and a specific radioactivity of 11-12 GBq mu mol(-1). The total synthesis and purification time required is about 80 min, starting from delivery of the [F-18] fluoride. [F-18] SFB remains an optimal reagent for labeling proteins and peptides with F-18 because of good conjugation yields and metabolic stability.
引用
收藏
页码:1655 / 1661
页数:7
相关论文
共 36 条
[1]   Synthesis and lipsome encapsulation of a novel 18F-conjugate of ω-conotoxin GVIA for the potential imaging of N-type Ca2+ channels in the brain by positron emission tomography [J].
Azarian, V ;
Gangloff, A ;
Seimbille, Y ;
Delaloye, S ;
Czernin, J ;
Phelps, ME ;
Silverman, DHS .
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2006, 49 (03) :269-283
[2]   Preparation of 18F-human serum albumin:: A simple and efficient protein labeling method with 18F using a hydrazone-formation method [J].
Chang, YS ;
Jeong, JM ;
Lee, YS ;
Kim, HW ;
Rai, GB ;
Lee, SJ ;
Lee, DS ;
Chung, JK ;
Lee, MC .
BIOCONJUGATE CHEMISTRY, 2005, 16 (05) :1329-1333
[3]   18F-labeled RGD peptide:: initial evaluation for imaging brain tumor angiogenesis [J].
Chen, XY ;
Park, R ;
Shahinian, AH ;
Tohme, M ;
Khankaldyyan, V ;
Bozorgzadeh, MH ;
Bading, JR ;
Moats, R ;
Laug, WE ;
Conti, PS .
NUCLEAR MEDICINE AND BIOLOGY, 2004, 31 (02) :179-189
[4]   1-[3-(2-[18F]fluoropyridin-3-yloxy)propyl]pyrrole-2,5-dione:: Design, synthesis, and radiosynthesis of a new[18F]fluoropyridine-based maleimide reagent for the labeling of peptides and proteins [J].
de Bruin, B ;
Kuhnast, B ;
Hinnen, F ;
Yaouancq, L ;
Amessou, M ;
Johannes, L ;
Samson, A ;
Boisgard, R ;
Tavitian, B ;
Dollé, F .
BIOCONJUGATE CHEMISTRY, 2005, 16 (02) :406-420
[5]   F-18 LABELING OF MONOCLONAL-ANTIBODIES AND FRAGMENTS WITH PRESERVATION OF IMMUNOREACTIVITY [J].
GARG, PK ;
GARG, S ;
ZALUTSKY, MR .
BIOCONJUGATE CHEMISTRY, 1991, 2 (01) :44-49
[6]   18F-fluorothiols:: A new approach to label peptides chemoselectively as potential tracers for positron emission tomography [J].
Glaser, M ;
Karlsen, H ;
Solbakken, M ;
Arukwe, J ;
Brady, F ;
Luthra, SK ;
Cuthbertson, A .
BIOCONJUGATE CHEMISTRY, 2004, 15 (06) :1447-1453
[7]   Production of [F-18]fluoroannexin for imaging apoptosis with PET [J].
Grierson, JR ;
Yagle, KJ ;
Eary, JF ;
Tait, JF ;
Gibson, DF ;
Lewellen, B ;
Link, JM ;
Krohn, KA .
BIOCONJUGATE CHEMISTRY, 2004, 15 (02) :373-379
[8]   Synthesis and in vitro evaluation of 18F- and 19F-labeled insulin:: A new radiotracer for PET-based molecular imaging studies [J].
Guenther, KJ ;
Yoganathan, S ;
Garofalo, R ;
Kawabata, T ;
Strack, T ;
Labiris, R ;
Dolovich, M ;
Chirakal, R ;
Valliant, JF .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (04) :1466-1474
[9]   ARYLTRIMETHYLAMMONIUM TRIFLUOROMETHANESULFONATES AS PRECURSORS TO ARYL [F-18] FLUORIDES - IMPROVED SYNTHESIS OF [F-18] GBR-13119 [J].
HAKA, MS ;
KILBOURN, MR ;
WATKINS, GL ;
TOORONGIAN, SA .
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1989, 27 (07) :823-833
[10]   The progress and promise of molecular imaging probes in oncologic drug development [J].
Kelloff, GJ ;
Krohn, KA ;
Larson, SM ;
Weissleder, R ;
Mankoff, DA ;
Hoffman, JM ;
Link, JM ;
Guyton, KZ ;
Eckelman, WC ;
Scher, HI ;
O'Shaughnessy, J ;
Cheson, BD ;
Sigman, CC ;
Tatum, JL ;
Mills, GQ ;
Sullivan, DC ;
Woodcock, J .
CLINICAL CANCER RESEARCH, 2005, 11 (22) :7967-7985